Overview

Stock Information

Symbol Market Last Change Volume
CGIX NASDAQ

View Stock Information

Latest Webcast

Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics and services some of the most prestigious medical institutions in the world. Our tests target cancers that are difficult to diagnose and predict treatment outcomes. These cancers include hematological, urogenital and HPV-associated cancers. We also offer a comprehensive range of non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. We have established strong research collaborations with major cancer centers such as Memorial Sloan-Kettering, The Cleveland Clinic, Mayo Clinic and the National Cancer Institute. For further information, please see www.cancergenetics.com.

Latest Press Releases

  • Mar23

    Cancer Genetics, Inc. Announces Record Revenue for Fourth Quarter and Full-Year 2016 and Provides 2017 Business Update Read More

  • Mar13

    Cancer Genetics to Present at "A Future Without Cancer Conference" on Friday, March 17 Read More

  • Mar10

    Cancer Genetics to Report Fourth Quarter & Year End 2016 Earnings and Business Update on March 23 Read More

Latest Events

  • Mar23

    4th Quarter and Fiscal Year 2016 Conference Call
    Date: March 23, 2017

  • Mar17

    A Future Without Cancer
    Date: March 17, 2017

  • Feb16

    Disruptive Growth & Healthcare Conference
    Date: February 16, 2017
    Location: New York, NY
    Read More

Contacts

Company
Cancer Genetics, Inc.
201 Route 17 North
2nd Floor
Rutherford, NJ 07070

Investor Relations
Cancer Genetics, Inc.
Panna Sharma
201-528-9200
panna.sharma@cgix.com


Discover Cancer Genetics Incorporated »

Our Research
With unparalleled excellence in oncology, our team is dedicated to empowering personalized cancer treatment.
Our Media
Stay current with the latest company news, articles, videos, and webinars.
Our Partners
CGI has established strong research collaborations with key thought leaders in oncology and major cancer centers in the U.S. and abroad.
Reports
Click here to login and view your reports.